Aurobindo Pharma
Aurobindo Pharma Share Price Chart
Aurobindo Pharma last traded at ₹1,700.00 (2026-10-13). Over the past month the stock moved +1.9%, three months the stock moved +16.1%, year the stock moved +52.0%. Its closing range over 52 weeks is ₹1,085.15 – ₹1,735.00, with the latest close 2.0% below the high.
Closing prices up to 2026-10-13.
About Aurobindo Pharma
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159)
Leading Pharmaceutical Company:.[1] The company is India’s 3rd-largest listed pharma company based on revenue & the largest generics company in the US. It is ranked among the top 10 generic companies in 8 European countries
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Aurobindo Pharma reported sales of ₹9,150.00 crore (+16.3%) and net profit of ₹1,032.00 crore (+25.2%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 9,150 | 1,880 | 21.00 | 1,032 | 17.78 |
| Mar 2026 | 8,853 | 1,750 | 20.00 | 921.00 | 15.86 |
| Dec 2025 | 8,646 | 1,773 | 21.00 | 910.00 | 15.67 |
| Sep 2025 | 8,286 | 1,678 | 20.00 | 848.00 | 14.61 |
| Jun 2025 | 7,868 | 1,603 | 20.00 | 824.00 | 14.20 |
| Mar 2025 | 8,382 | 1,760 | 21.00 | 903.00 | 15.56 |
| Dec 2024 | 7,979 | 1,578 | 20.00 | 846.00 | 14.56 |
| Sep 2024 | 7,796 | 1,566 | 20.00 | 817.00 | 14.07 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +8.0% | +8.5% | +10.6% | +4.0% | +6.3% | +8.4% | +5.6% | +16.3% |
| Operating profit growth | +14.1% | -1.3% | +6.0% | -0.9% | +7.2% | +12.4% | -0.6% | +17.3% |
| Net profit growth | +8.6% | -10.0% | -0.4% | -10.2% | +3.8% | +7.6% | +2.0% | +25.2% |
| EPS growth | +8.9% | -8.9% | +0.3% | -9.5% | +3.8% | +7.6% | +1.9% | +25.2% |
| OPM % | 20.0% | 20.0% | 21.0% | 20.0% | 20.0% | 21.0% | 20.0% | 21.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Aurobindo Pharma reported sales of ₹33,653.00 crore (+6.1%) and net profit of ₹3,503.00 crore (+0.5%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 33,653 | 6,846 | 20.00 | 3,503 | 60.34 |
| Mar 2025 | 31,724 | 6,551 | 21.00 | 3,484 | 59.49 |
| Mar 2024 | 29,002 | 5,826 | 20.00 | 3,169 | 54.15 |
| Mar 2023 | 24,855 | 3,707 | 15.00 | 1,928 | 32.90 |
| Mar 2022 | 23,455 | 4,396 | 19.00 | 2,647 | 45.20 |
| Mar 2021 | 24,775 | 5,278 | 21.00 | 5,334 | 91.05 |
| Mar 2020 | 23,099 | 4,849 | 21.00 | 2,844 | 48.56 |
| Mar 2019 | 19,564 | 3,952 | 20.00 | 2,364 | 40.36 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +18.8% | +18.1% | +7.3% | -5.3% | +6.0% | +16.7% | +9.4% | +6.1% |
| Operating profit growth | +4.8% | +22.7% | +8.8% | -16.7% | -15.7% | +57.2% | +12.4% | +4.5% |
| Net profit growth | -2.4% | +20.3% | +87.6% | -50.4% | -27.2% | +64.4% | +9.9% | +0.5% |
| EPS growth | -2.4% | +20.3% | +87.5% | -50.4% | -27.2% | +64.6% | +9.9% | +1.4% |
| OPM % | 20.0% | 21.0% | 21.0% | 19.0% | 15.0% | 20.0% | 21.0% | 20.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Aurobindo Pharma.
Get Free AI Stock Analysis FREE →Latest News
-
Aurobindo Pharma rises on getting USFDA’s final nod to manufacture, market Perampanel tablets
-
Aurobindo Pharma gets USFDA’s final nod to manufacture, market Perampanel tablets
-
Aurobindo Pharma Gets USFDA Nod for Generic Epilepsy Tablets
-
Aurobindo Pharma shares in focus on final USFDA approval for Perampanel tablets - Moneycontrol.com
-
Stocks to Watch Today: Aurobindo Pharma, Highway Infra, NCC, Blue Dart, Symbiotec Pharma, Shadowfax,... - Moneycontrol.com
-
Stocks to watch, Oct 1: Auto stocks, Tech Mahindra, NCC, Aurobindo Pharma, Linde India, Mahindra Lifespace, Transrail Lighting - Upstox
-
Stocks to Watch Today: Aurobindo Pharma, Highway Infra, NCC, Blue Dart, Symbiotec Pharma, Shadowfax,... - Moneycontrol.com
-
Stocks to watch, Oct 1: Auto stocks, Tech Mahindra, NCC, Aurobindo Pharma, Linde India, Mahindra Lifespace, Transrail Lighting - Upstox
-
Stocks to Watch Today: Aurobindo Pharma, Highway Infra, NCC, Blue Dart, Symbiotec Pharma, Shadowfax,... - Moneycontrol.com
-
Stocks to watch, Oct 1: Auto stocks, Tech Mahindra, NCC, Aurobindo Pharma, Linde India, Mahindra Lifespace, Transrail Lighting - Upstox
Frequently Asked Questions
What is the share price of Aurobindo Pharma today?
Aurobindo Pharma shares were last quoted at ₹1,700.00 (+0.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Aurobindo Pharma?
Aurobindo Pharma has a price-to-earnings (P/E) ratio of 25.23 and a price-to-book (P/B) ratio of 2.55. The industry P/E is 53.33.
What is the 52-week high and low of Aurobindo Pharma?
The 52-week high of Aurobindo Pharma is ₹1,739.60 and the 52-week low is ₹1,066.00.
What is the market cap of Aurobindo Pharma?
The market capitalisation of Aurobindo Pharma is about ₹99,392.58 crore.
How did Aurobindo Pharma perform in its latest quarterly results?
In the latest quarter (Jun 2026), Aurobindo Pharma reported sales of ₹9,150.00 crore (+16.3%) and net profit of ₹1,032.00 crore (+25.2%), compared with the same quarter last year.
Is Aurobindo Pharma a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Aurobindo Pharma has a 3-year ROE of 11.00%, 3-year profit growth of 23.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Aurobindo Pharma?
Promoters hold about 51.88% of Aurobindo Pharma.
Which sector does Aurobindo Pharma belong to?
Aurobindo Pharma belongs to the Pharmaceuticals & Drugs sector.